Dorsey Wright & Associates Kodiak Sciences Inc. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$45.05 - $59.27 $41,130 - $54,113	-913 Closed	0 $0
Q1 2020 Apr 20, 2020	SELL	$38.18 - $73.95 $2,290 - $4,437	-60 Reduced 6.17%	913 $44,000
Q4 2019 Jan 31, 2020	BUY	$13.9 - $76.65 $291 - $1,609	21 Added 2.21%	973 $70,000
Q3 2019 Oct 31, 2019	BUY	$10.24 - $17.57 $9,748 - $16,726	952 New	952 $14,000

105

39.8M

7.6K

3.5K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $138M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.